RUO
Also known as: Research Use Only, research use only
Research Use Only — a regulatory designation meaning the tool provides research scores, not clinical diagnoses. The same label used by REVEL, CADD, AlphaMissense, and PolyPhen-2.
Source: FDA 21 CFR 809.10(c)(2) — labeling requirements for Research Use Only products. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-809/subpart-B/section-809.10
Primary reference ↗Research Use Only (RUO) is a regulatory designation for products intended for research applications, not for use in clinical diagnosis or treatment decisions. RUO products are not FDA-cleared or approved as diagnostic devices.
What It Means in Practice
An RUO designation means:
- The tool provides computational evidence to support research
- Clinical laboratories may use RUO scores within their own validated workflows (as part of a laboratory-developed test, or LDT)
- The responsibility for clinical validation lies with the laboratory, not the tool developer
Precedent: Established Computational Variant Predictors
Major computational variant effect predictors are all RUO:
| Tool | RUO | ACMG Evidence Code |
|---|---|---|
| REVEL | Yes | PP3/BP4 |
| CADD | Yes | PP3/BP4 |
| AlphaMissense | Yes | PP3/BP4 |
| PolyPhen-2 | Yes | PP3/BP4 |
| SIFT | Yes | BP4 |
| ESM-2 (NeuroAutomata) | Yes | PP3/BP4 |
These tools contribute ACMG evidence criteria PP3 (computational evidence pathogenic) and BP4 (computational evidence benign) when incorporated into a clinical variant classification workflow.
RUO Is Not a Limitation
RUO does not mean the tool is unvalidated or unreliable. It means the tool is positioned appropriately within the clinical evidence hierarchy. The DMS validation benchmarks in the ESM-2 Benchmark Series document exactly where and how well the scores perform — which is what clinical labs need to assess before incorporating any computational tool.